Oocyte Cryopreservation
This study is ongoing, but not recruiting participants.
Sponsor:
Weill Medical College of Cornell University
Information provided by (Responsible Party):
Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:
NCT01696786
First received: September 27, 2012
Last updated: May 14, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The specific aim of this study is to further develop methods of oocyte cryopreservation and evaluate their impact on reproductive outcomes.
| Condition | Intervention |
|---|---|
|
Fertility Preservation |
Procedure: Oocyte cryopreservation |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Oocyte Cryopreservation |
Resource links provided by NLM:
Further study details as provided by Weill Medical College of Cornell University:
Primary Outcome Measures:
- Survival rate of cryopreserved oocytes with each cryopreservation method [ Time Frame: 1 year ] [ Designated as safety issue: No ]Survival rate of cryopreserved oocytes with each cryopreservation method
- Pregnancy rate following thawing/warming of oocytes [ Time Frame: 1 year ] [ Designated as safety issue: No ]Pregnancy rate following thawing/warming of oocytes
- Implantation rate per embryo transferred [ Time Frame: 1 year ] [ Designated as safety issue: No ]Implantation rate per embryo transferred
| Estimated Enrollment: | 250 |
| Study Start Date: | June 2009 |
| Estimated Study Completion Date: | February 2014 |
| Estimated Primary Completion Date: | February 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: Oocyte cryopreservation |
Procedure: Oocyte cryopreservation
Oocyte (egg) cryopreservation (freezing) to preserve fertility
|
Eligibility| Ages Eligible for Study: | up to 42 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
Any consenting female who wishes to freeze unfertilized oocytes and are:
- at risk for ovarian hyperstimulation syndrome (enlarged ovaries with abdominal fluid accumulation) and postponement of pregnancy has been recommended.
- a cancer patient anticipating treatment and have been cleared by the oncologists for ovarian stimulation.
- a female who seeks to preserve her future fertility and does not wish to use donor or partner sperm to fertilize her eggs.
- a donor egg recipient who elects to have some of the eggs obtained fertilized with husband/partner sperm and the rest cryopreserved for future use.
- a patient for whom the partner's sperm retrieval or production has failed and donor sperm is not an option.
- a patient who, for religious or ethical reasons, wants to limit the number of fresh oocytes exposed to sperm (fertilization) and do not want to either discard or donate the excess oocytes.
AND
- has been clinically and psychologically approved for ovarian stimulation
- age between 12 and 42 years, inclusive, at time of informed consent.
- willing and able to comply with the protocol.
- willing to provide follow-up information from her OB/GYN of any CVS/amniocentesis results, as well as information on obstetrical outcome.
- agree to undergo intracytoplasmic sperm injection (ICSI) when oocytes are thawed.
For cancer patients:
- No significant ovarian pathology as judged by physical exam and radiological studies;
- Patient's general condition and prognosis deemed favorable for surgery and chemo/radio therapy;
- No other major medical illness,
- Oncologist approval for the ovarian stimulation and egg retrieval.
Exclusion Criteria:
Age > 42 Subjects who do not meet the inclusion criteria will be ineligible for participation in this study.
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Weill Medical College of Cornell University |
| ClinicalTrials.gov Identifier: | NCT01696786 History of Changes |
| Other Study ID Numbers: | 0903010292 |
| Study First Received: | September 27, 2012 |
| Last Updated: | May 14, 2013 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Infertility Genital Diseases, Male Genital Diseases, Female |
ClinicalTrials.gov processed this record on May 16, 2013